The authors found that gonadotropin resistance has the same immune mechanism as myasthenia gravis, and they confirmed that the patient serum contained a substance similar to gamma globulin, which inhibited the specific binding of FSH to the receptor in vitro, possibly explaining the ovary’s non-response to gonadotropin stimulation. Here, BRD2 is linked to myasthenia gravis.